Ashley Cheng

Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial

Robin Kate Kelley, Makoto Ueno, Changhoon Yoo et al. · The Lancet · 2023 · 891 citations · Full text

Urology, Surgical Oncology, Gastrointestinal Oncology +5

Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial

Sun Young Rha, Do‐Youn Oh, Patricio Yañez et al. · The Lancet Oncology · 2023 · 521 citations

Chemotherapy Versus Placebo, Gastrointestinal Oncology, Medicine +8

Treatment outcomes of nasopharyngeal carcinoma in modern era after intensity modulated radiotherapy (IMRT) in Hong Kong: A report of 3328 patients (HKNPCSG 1301 study)

Kwok‐Hung Au, Roger K.C. Ngan, Alice Ng et al. · Oral Oncology · 2017 · 280 citations

Hknpcsg 1301, Radiation Therapy, Medicine +9

Concurrent and Adjuvant Chemotherapy for Nasopharyngeal Carcinoma: A Factorial Study

Dora L.�W. Kwong, Jonathan S. T. Sham, Gordon K.�H. Au et al. · Journal of Clinical Oncology · 2004 · 265 citations · Full text

Analysis of Plasma Epstein-Barr Virus DNA in Nasopharyngeal Cancer After Chemoradiation to Identify High-Risk Patients for Adjuvant Chemotherapy: A Randomized Controlled Trial

Anthony T.�C. Chan, Edwin P. Hui, Roger K.C. Ngan et al. · Journal of Clinical Oncology · 2018 · 240 citations

Plasma Epstein-barr Virus, Medicine, Immunology +13